HighMark Wealth Management »

Centessa Pharmaceuticals shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.8M 237k 24.25
2025-06-30 $3.1M 237k 13.14
2025-03-31 $3.4M 236k 14.38
2024-12-31 $2.8M 166k 16.75
2024-09-30 $2.7M 167k 15.99
2024-06-30 $840k 93k 9.03

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Us Vlu (IUSV)
Wells Fargo & Company (WFC)
Performant Finl (PHLT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Anaptysbio Inc Common (ANAB)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Axogen (AXGN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Neogenomics Com New (NEO)

View all positions for HighMark Wealth Management

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
General Atlantic
FMR
Henderson Group
Farallon Capital Management
First Light Asset Management
Siren
TCG Crossover Management
Perceptive Advisors
Commodore Capital
Franklin Resources
Rtw Investments
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals